Conference abstract · 17 Sep 2018
Conference abstractPublished 15 Apr 2013
A novel approach to pathogenesis and treatment of fuchs endothelial corneal dystrophy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background:Fuchs' endothelial corneal dystrophy (FECD) is a significant cause of corneal blindness and a leading cause of corneal transplantation. The mechanism of corneal endothelial cell loss in FECD is currently not known and the only available treatment for FECD is corneal transplantation. It has been shown by our laboratory that there is an oxidant-antioxidant imbalance in FECD as compared to normal corneal endothelium (CE). Our previous studies have shown accumulation of oxidized DNA lesions in FECD, co-localization of oxidative DNA damage and apoptosis, and down regulation of Nrf2 (NF-E2-related factor 2), which is a major transcription factor responsible for activation of antioxidant genes. We detected an increased level of p53 and phospho-p53 in FECD compared to normal endothelium. Increased activation of p53 and down regulation of Nrf2 in FECD suggests that p53 and Nrf2 plays a critical role in complex mechanisms regulating oxidative-stress-induced apoptosis in FECD. Aim: Sulforaphane (SFN) is a naturally occurring glucosinolate, which confer cytoprotection by activating Nrf2. The purpose of this study was to investigate the effect of SFN on Nrf2 activation and apoptosis in FECD. Materials & Methods: Specimens of corneal endothelial cells (CECs) with Descemet?s membrane were cut in 2 halves and one half was treated with 50 μM SFN for 4 hours at 37°C. In separate specimens, SFN treatment was followed by induction of oxidative stress by incubation with tert-Butyl hydroperoxide (tBHP) (500 μM for 4 hours). CECs apoptosis was detected by a TUNEL assay using confocal microscopy. Cellular localization of Nrf2 and p53 was assessed by immunohistochemistry. Cell counting was performed by Image-J (NIH) software. Western blot and Real-time PCR were used to analyze Protein levels and mRNA relative expression in (FECDi) and (HCECi) cell lines. Results: CECs apoptosis in FECD was 31%, decreasing to 14% (n=5, p<0.01) with SFN treatment. SFN decreased CECs apoptosis by 43% (n=6, p<0.05) in specimens exposed to pro-oxidants. Nrf2 protein level was significantly increased in SFN-treated as compared to non-treated CECs (n=4, p=0.03). Exposure of normal CECs to tBHP increased nuclear localization of Nrf2, which was further enhanced by SFN. Oxidative stress did not increase nuclear localization of Nrf2 in FECD, but pre-treatment with SFN significantly enhanced nuclear translocation of Nrf2. FECD CECs treated with SFN demonstrated lower level of p53 in basal and oxidative stressed condition. SFN increases protein level of Nrf2 in normal endothelium, but its effect is enhanced in pro-oxidant condition in FECD. SFN, interestingly, increases protein level of DJ-1 in FECD at baseline and in pro-oxidant condition. SFN significantly increases mRNA level of Nrf2, NQO1, and DJ-1 in normal CE and Hmox-1 in pre-oxidant co condition. Conclusions: SFN is a potent antioxidant agent, which significantly diminishes CECs apoptosis and potentially provides novel pharmacotherapeutic agent.
Subjects
Ophthalmology & OptometryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 16 May 2016
Genetic Scenario of Fuchs’ Endothelial Corneal Dystrophy in India
Conference abstract · 5 Jul 2011
Fuchs’ endothelial corneal dystrophy
Mini review · 9 Nov 2021
UBIAD1 and pathogenesis of schnyder’s crystalline corneal dystrophy.
Mini review · 2021
UBIAD1 and pathogenesis of schnyderâ??s crystalline corneal dystrophy.
More from this journal
The newest in Journal of Clinical and Experimental Ophthalmology.
Research article · 6 Oct 2026
Visual performance of wavefront-shaping extended-depth-of-focus intraocular lenses in Japanese eyes after previous laser in situ keratomileusis
Short communication · 30 Aug 2026
Vision Science in the Modern Era: Integrating Neuroscience, Genetics, and Technology
Commentary · 3 Aug 2026
Emerging Frontiers in Experimental Ophthalmology: Innovations and Translational Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Experimental Ophthalmology
- SubjectOphthalmology & Optometry
- BylineArticles whose byline prints “Alireza Ziaei”

